Status:
UNKNOWN
Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 Stage
Lead Sponsor:
Fudan University
Conditions:
Nasopharyngeal Carcinoma
Eligibility:
All Genders
18-60 years
Phase:
PHASE3
Brief Summary
Up to now, IMRT has largely improved the local control of locally advanced nasopharyngeal carcinoma (NPC), leaves the distant metastasis as the main treatment failure modality of patients with bulky l...
Detailed Description
We aim to conduct "A Phase III Randomized Trial of Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 Stage" to evaluate the effectiveness and compliance of gemic...
Eligibility Criteria
Inclusion
- AJCC/UICC 8th edition N3 nasopharyngeal carcinoma
- Pathology: WHO II/II
- No prior anti-tumor treatment
- Age 18-60
- KPS≥70
- Adequate blood supply
- Informed consent obtained
Exclusion
- Pathology: WHO I
- Pregnant
- Combined with other malignant tumor
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT03403829
Start Date
January 1 2018
End Date
December 31 2020
Last Update
July 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fudan Universtiy Shanghai Cancer Centre
Shanghai, Shanghai Municipality, China, 200032